Home > EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine.

European Monitoring Centre for Drugs and Drug Addiction. [EMCDDA] (2012) EMCDDA-Europol joint report on a new psychoactive substance: 4-methylamphetamine. Luxembourg: Publications Office of the European Union. 40 p.

[img] PDF (EMCDDA-Europol - 4-methylamphetamine) - Published Version
340kB

At the end of 2011 and in 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methylamphetamine. The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4-methylamphetamine as stipulated by Article 5.1 of the Decision.

Table of contents
• Introduction
• Information collection process
• Information required by Article 5.2 of the Decision
• Information from the EMA as requested by Article 5.3 of the Decision
• Summary of findings
• Conclusions
• Annexes


Item Type:Evidence resource
Publication Type:Report
Drug Type:New psychoactive substance, CNS stimulants
Intervention Type:AOD disorder harm reduction
Source:EMCDDA
Date:2012
Pages:40 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
B Drugs and alcohol substances > CNS stimulants
VA Geographic area > Europe
A Drugs and alcohol use, abuse, and dependence > Prevalence of drugs and alcohol use
A Drugs and alcohol use, abuse, and dependence > Drugs and alcohol effects and consequences

Repository Staff Only: item control page